February 7-12, 1998
Catamaran Hotel and Conference Center
3999 Mission Boulevard
San Diego, California 92109
1-619-488-1081 - F: 1-619-488-0901
Conference Chairs:
Jeff Chalmers
Ohio State University
&
Rob Arathoon
Genentech, Inc.
Engineering Foundation
345 East 47th Street
New York, NY 10017
T: 1-212-705-7836 - F: 1-212-705-7441
- E: engfnd@aol.com
www.engfnd.org
The conference chairs, the organizing committee and the Engineering Foundation would like to thank the following organizations for their financial support of this conference.
Saturday, February 7, 1998
3:00 p.m. - 9:00 p.m. Registration and Check-In (Lobby)
5:30 p.m. - 7:00 p.m. Dinner
7:00 p.m. - 10:00 p.m. Conference Opening and Welcome
Dr. Robert Arathoon, Conference Co-Chair
Professor Jeff Chalmers, Conference Co-Chair
Allen Laskin, Engineering Foundation
7:15 p.m. - 7:45 p.m. HISTORICAL PERSPECTIVE
"Historic Perspective in Cell Culture Engineering"
Professor Daniel I. C. Wang
Massachusetts Institute of Technology
7:45 p.m. - 8:15 p.m. Dr. Tony Lubiniecki
SmithKline Beecham
8:15 p.m.- 10:00 p.m. Opening Reception/Social Hour
Sunday, February 8, 1998
7:00 a.m. - 8:30 a.m. Breakfast
8:30 a.m. QUANTIFICATION APPROACHES IN LARGE SCALE
CELL CULTURE
Session Co-Chairs:
Professor Carol Heath, Iowa State University
Dr. Weichang Zhou, Merck Research Industries
8:35 a.m. - 9:05 a.m. "From Applied Research to Industrial
Application:
The Monitoring of Intracellular Necleotides as a Useful
Tool in the Development and Characterization of Mammalian
Cell Culture Processes"
Dr. Stephanos T. Grammatikos
Dr. Karl Thomae GMBH
9:05 a.m. - 9:35 a.m. "Comparison of Large Scale
Batch and Continuous Perfusion Processes for Production of
Mammalian Cell Derived Recombinant Proteins"
Gregory MacMichael
Medarex & Chiron Corp.
9:35 a.m. - 10:05 a.m. "Characterization of Cellular
Nutrition Requirements, Cell Metabolism and Cell Death Mechanism
of a Fed-Batch Recombinant NSO Culture"
Weichang Zhou
Merck Research Laboratories
10:05 a.m. - 10:35 a.m. "Improved Glycosylation of
Recombinant Proteins Produced in CHO Cells Overexpressing
Human
b1,4-galactosyltransferase and/or a 2,3-sialtransferase"
Dr. Lynne Krumme
Genentech, Inc.
10:35 a.m. - 11:00 a.m. Coffee Break
11:00 a.m. - 11:30 a.m. "Multiple Steady States in
Continuous Cultivation of Hybridoma Cells"
Professor Wei-Shou Hu
University of Minnesota
11:30 a.m. - 12:00 noon "Regulation of NCAM Polysialylation
by pCO2 and pH in Culture"
Professor William Miller
Northwestern University
12:00 noon - 12:30 p.m. "The "Push-to-Low"
Approach for Feeding Optimization of High-Density Perfusion
Animal Cell Culture"
Dr. Konstantin Konstantinov
Bayer Corp.
12:30 p.m. - 2:00 p.m. Lunch
2:00 p.m. - 4:00 p.m. Ad hoc Session/Free Time
4:00 p.m. - 5:00 p.m. POSTER SESSION I
5:00 p.m. - 5:30 p.m. Special Lecture for Cell Identification,
Selection and Separation
"Antigen Characterization of Breast Cancer Cells"
Dr. M. Mitchell
University of California at San Diego
5:30 p.m. - 7:30 p.m. PRODUCT QUANTIFICATION AND FACTORS
IN CELL CULTURE THAT AFFECT PRODUCT QUALITY
Session Co-Chair:
Dr. Kenneth Seamon, Immunex Corporation
Dr. Sadettin Ozturk, Bayer Corp.
5:30 p.m. - 6:00 p.m. "Regulatory Issues in Evaluating
Product Quality in Cell Culture"
Dr. J. O'Connor
Genentech Inc.
6:00 p.m. - 6:30 p.m. "Product Quality Characteristics
and Impact of Cell Culture Parameters"
James N. Thomas
Immunex Corporation
6:30 p.m. - 7:00 p.m. "Characterization of the Expression
Construct in Cells Used for Production Benefix"
Dr. Leonard
Genetics Institute
7:00 p.m. - 7:30 p.m. "Ammonia Affects the N-Glycan
Structures of Recombinant Proteins: Exploring the Mechnisms"
Dr. Martin Gawilitzek
Genentech Inc.
7:30 p.m. - 9:00 p.m. Dinner
9:00 p.m. - 10:00 p.m. Social Hour
Monday, February 9, 1998
7:00 a.m. - 8:30 a.m. Breakfast
8:30 a.m. - 12:00 Noon USE OF ANIMAL DERIVED COMPONENTS IN
CELL CULTURE
Session Chair:
Dr. Tony Lubiniecki, SmithKline Beecham
8:30 a.m. - 9:00 a.m. "An Overview of Viral and Virus-Like
Agents in Cell Culture Systems"
Dr. John Petricciani
International Association for Biological Standardization
9:00 a.m. - 10:00 a.m. KEYNOTE LECTURE
"Prion Biology and Diseases - Potential Problems
in the Preparation of Prion Free Therapeutics"
Professor Stan Prusiner
University of California, San Francisco
10:00 a.m. - 10:30 a.m. Coffee Break
10:30 a.m. - 11:00 a.m. "PhRMA Risk Assessment Study
for BSE in Animal-Derived Raw Materials"
Dr. Frederic G. Bader
Centocor, Inc.
11:00 a.m. - 11:30 a.m. "Collective Experiences of
Adventitious Viruses of Animal
Derived Raw Materials and What Can Be Done About Them"
Dr. R. Levings
USDA APHIS, Ames, Iowa
11:30 a.m. - 12:00 noon "Approaches to Prevention
of Virus Contamination of Cell Culture Medium"
Dr. Gian Polastri
Genentech, Inc.
12:00 noon - 1:30 p.m. Lunch
1:30 p.m. - 3:00 p.m. Ad hoc Session/Free Time
3:00 p.m. - 5:00 p.m. WORKSHOP:
MONITORING AND CONTROL OF CELL CULTURE PROCESSES
Lawrence Forman, Forman Consulting
Georg Schmid, F. Hoffman LaRoche
5:00 p.m. STEM CELLS: DIFFERENT SYSTEMS AND ENGINEERING
Session Co-Chairs:
Professor William Miller, Northwestern University
Professor David Humes, University of Michigan
Introduction and Overview
Professor William Miller
5:00 p.m. - 5:30 p.m. "Use of Kidney Stem Cells to
Engineer a Bioartificial Tubule"
Professor David Humes
University of Michigan
5:30 p.m. - 6:00 p.m. "Building Blood Vessels de
Novo"
Professor Charles Little
Medical University of South Carolina
6:00 p.m. - 6:30 p.m. "Neural Stem Cells"
Professor John Kessler
Albert Einstein College of Medicine
6:30 p.m. - 7:00 p.m. "Modeling Organogenesis Using
Chemical Engineering Methaphors"
Professor Lars Nielsen
University of Queensland
7:00 p.m. - 7:15 p.m. Concluding Remarks
Professor David Humes
University of Michigan
7:30 p.m. - 9:00 p.m. Dinner
9:00 p.m. - 10:00 p.m. Social Hour
Tuesday, February 10, 1998
7:00 a.m. - 8:30 a.m. Breakfast
8:30 a.m. - 12:00 Noon CELL ENGINEERING FOR CELL CULTURE
Session Co-Chairs
Professor Eleftherios T. Papoutsakis, Northwestern University
Professor Peter Gray, University of New South Wales
8:30 a.m. - 9:15 a.m. "Metabolic Engineering
of the CHO Cell Cycle by Regulated Expression of Critical
Genes"
Professor Jay Bailey
ETH, Zurich
9:15 a.m. - 9:45 a.m. "The Effect of Recombinant
Insulin-Like Growth Factor One (IGF-1) Production on the
Expression of IGF-1 Receptors and the Interaction With IGF-1
Binding Proteins in the Super- CHO Cell Line"
Professor Peter Gray
University of New South Wales
9:45 a.m. - 10:15 a.m. Coffee Break
10:15 a.m. - 10:45 a.m. "Engineering CHO Cells to
Achieve a Non-Growth-Associated Production of Foreign Proteins"
Professor Dhinakar Kompala
University of Colorado
10:45 a.m. - 11:15 a.m. "Suppressing The Cell Death
Cascade in Virally Infected Mammalian Cells"
Professor Michael Betenbaugh
Johns Hopkins University
11:15 a.m. - 11:45 a.m. "Restructuring the Carbohydrates
of Recombinant Glycoproteins"
Professor Nigel Jenkins
DeMontfort University
12:00 noon - 1:30 p.m. Lunch
1:30 p.m. - 3:00 p.m. POSTER SESSION I
3:00 p.m. - 5:30 p.m. Activities at Balboa Park
5:30 p.m. - 7:30 p.m. Dinner at Balboa Park
7:30 p.m. Return to Hotel
8:00 p.m. - 9:00 p.m. KEYNOTE ADDRESS
"Of Genes and Genomes"
Professor David Botstein
Stanford University
9:00 p.m. - 10:30 p.m. POSTER SESSION II with Social Hour
Wednesday, February 11, 1998
7:00 a.m. - 8:30 a.m. Breakfast
8:30 a.m. - 12:00 Noon CELL IDENTIFICATION, SELECTION AND
SEPARATION
Session Co-Chairs
Professor Eleftherios T. Papoutsakis, Northwestern University
Dr. Jim Bender, Baxter Healthcare
8:30 a.m. - 9:10 a.m. "Identification of Therapeutic
Cell Populations Using Monoclonal Antibodies Directed at
Cell Surface Antigens"
Dr. Jim Bender
Baxter Healthcare
9:10 a.m. - 9:50 a.m. "Fast Cell Separation With
Immunomagnetic Colloid and Flow-Through Magnetic Sorter"
Dr. Maciej Zborowski
The Cleveland Clinic Foundation
9:50 a.m. - 10:20 a.m. Coffee Break
10:20 a.m. - 10:50 a.m. "Development of An Analytical
Magnetophoresis System for the Quantitation of the Magnetic
Susceptibility of Immunomagnetically Labeled Hematopoietic
Stem Cells"
Dr. Richard Schwartz
SyStemix Inc.
10:50 a.m. - 11:20 a.m. "Mammalian Cell Separation
by Ultrasonic Forces"
Dr. James M. Piret
University of British Columbia
11:30 a.m. - 1:00 p.m. Lunch
1:30 p.m. - 3:00 p.m. Ad hoc Session/Free Time
3:00 p.m. - 5:00 p.m. POSTER SESSION II
5:00 p.m. - 7:30 p.m. STRESS IN BIOREACTORS
Session Co-Chairs:
Professor James Piret, University of British Columbia
Dr. Konstantin Konstantinov, Bayer Corp.
5:00 p.m. - 5:40 p.m. "Differential Gene Regulation
Induced by Flow in Vascular Cells: Implications for Gene
Therapy"
Professor Larry V. McIntire
Rice University
5:40 p.m. - 6:05 p.m. "The Interplay of Agitation
Intensity and Media Additives on Receptor Expression"
Professor Eleftherios T. Papoutsakis
Northwestern University
6:05 p.m. - 6:30 p.m. "Variable Functions of bcl-2
in Mediation Bioreactor Stress and Nutrient Deprivation-Induced
Apoptosis in Hybridoma Cells"
Mohamed Al-Rubeai
University of Birmingham
6:30 p.m. - 6:55 p.m. "A Framework for the Study
of Cell Death in Culture"
Professor Gregory Stephanopoulos
Massachusetts Institute of Technology
6:55 p.m. - 7:20 p.m. "Fatty Acids Enhance the Robustness
of Mammalian Cells in Agitated Cultures"
Professor Michael Butler
University of Manitoba
7:30 p.m. - 9:00 p.m. Dinner
9:00 p.m. - 10:00 p.m. Social Hour
Thursday, February 12, 1998
7:00 a.m. - 8:30 a.m. Breakfast
8:30 a.m. - 10:20 a.m. ANTIBODY ENGINEERING
Session Co-Chairs:
Dr. Paul Carter, Genentech, Inc.
Dr. Robert Arathoon, Genentech, Inc.
8:30 a.m. - 8:55 a.m. "TBA"
Kathryn Stein
FDA
8:55 a.m. - 9:20 a.m. "XenoMouseTM - A Robust
Technology for Production of Therapeutic Human Monoclonal
Antibodies"
Dr. Aya Jakobovits
Abgenix, Inc.
9:20 a.m. - 9:55 a.m. "Human Antibodies from
Phage"
Dr. P.R. Tempest
CAT, UK
9:55 a.m. - 10:20 a.m. "Clinical Development
of RituxanTM (IDEC-C2B8): First Monoclonal Antibody for
the Treatment of Lymphoma"
Dr. Antonio J. Grillo-Lopez
IDEC Pharmaceuticals Corporation
10:20 a.m. - 10:45 a.m. Coffee Break
10:45 a.m. - 12:25 p.m. VIRAL VECTORS AND RAPID EXPRESSION
SYSTEMS
Session Co-Chairs
Dr. John Aunins, Merck & Co.
Dr. Amy Murmane, SmithKline Beecham Pharma
10:45 a.m. - 11:10 a.m. "Production Issues for Adenoviral
Gene Therapy Vectors"
Dr. Kathleen Hehir
Genzyme Inc.
11:10 a.m. - 11:35 a.m. "Applications of GFP
(Green Fluorescent Protein) to Monitor Transient Gene Expression
in Cell Culture Processes"
Dr. Amy Murnane
SmithKline Beecham Pharma
11:35 a.m. - 12:00 noon "Transient Transfection in
Mammalian Cells A Basic Study for an Efficient and Cost-Effective
Scale Up Process"
Dr. Ernst-Jurgen Schlaeger
F. Hoffmann La Roche Ltd.
12:00 noon - 12:25 p.m. "Evolution of Adenovirus Vectors"
Professor R. Parks
McMaster University
12:15 p.m. Lunch and Adjournment